Aging is a primary risk factor for neurodegenerative diseases like Alzheimer’s, but mounting evidence suggests that early life stress can play an equally significant role in triggering what experts are calling stress related dementia. Childhood adversity—whether emotional, physical, or psychological—has been linked to chronic neuroinflammation, accelerated brain aging, and increased cognitive decline later in life.
This article explores how early life adversity may contribute to the development of stress-related dementia through changes in brain structure, inflammation, and neurological biomarkers. In particular, it highlights the vulnerability in women, who are statistically more likely to suffer from both early life stress and later dementia.
Analytical Approach for Peripheral Biomarkers of Neuroinflammation and Neurodegeneration
Using Simoa® ultra-sensitive digital immunoassays, the study measured blood levels of glial fibrillary acidic protein (GFAP), neurofilament light chain (NfL), and p-Tau 181 in 179 participants with or without a history of ELS.
Key Findings Related to Stress Related Dementia:
1. Increased Neuroinflammation
Women with a history of severe ELS exhibited higher levels of GFAP as they aged, indicating heightened neuroinflammatory activity and increased glial cell damage.
2. Higher Risk of Neurodegeneration
NfL, a biomarker for axonal damage and neuronal death, displayed a bimodal distribution, with a more pronounced increase in individuals with high adverse childhood experiences (ACE) scores and no ELS exposure than in individuals with low to moderate ACE scores. The authors speculate that this bimodal distribution may represent stress “inoculation” or “resilience”, where low-to-moderate ELS may build adaptability and lower stress reactivity in adulthood.
3. Structural Brain Changes Linked to Neurodegeneration
Generalized additive model (GAM) analysis of brain and ventricular volumes revealed:
- Decreased total brain volume (TBV) and total gray matter volume (tGMV)
- Increased ventricular size, an indicator of brain atrophy
These findings suggest a strong interaction between ELS severity, aging, and structural brain changes relevant to neurodegeneration.
4. Association with Poorer Cognitive Performance
The researchers’ models demonstrated an inverse correlation between cognitive performance and the interaction effect of ACE levels and age. Strikingly, the worst cognitive dysfunction was observed in individuals with higher ACE scores at younger ages.
Why Women May Be More Susceptible to Stress Related Dementia
This research is particularly relevant to women’s health, given their higher risk of developing AD and related dementias. The findings underscore the importance of considering ELS exposure in neurological care, particularly in early detection and intervention strategies for individuals at risk of neurodegenerative disorders.
Early identification of ELS-exposed individuals could pave the way for targeted screening and preventative care to delay or mitigate the onset of dementia-related conditions.
Further research is necessary to better understand the precise mechanisms by which ELS contributes to later-life neurodegeneration. Identifying effective therapeutic targets and optimal windows for early intervention will be crucial in developing successful prevention strategies.
Conclusion
By measuring key biomarkers associated with neuroinflammation, neurodegeneration, and cognitive function, this study provides critical evidence linking childhood adversity to long-term neurological health risks. It enhances our understanding of how early-life stress influences brain aging and cognitive decline. Moreover, these findings bring us closer to developing targeted interventions that may improve cognitive outcomes in individuals at risk of accelerated brain aging.
At Quanterix, we support breakthroughs in neurology research by providing ultra-sensitive Simoa® assays that accelerate biomarker discoveries and their translation into clinical applications for neurodegenerative diseases and inflammatory CNS disorders. This study exemplifies the power of cutting-edge biomarker technology in advancing our understanding of brain health.
Download the Blood Biomarkers of Brain Health brochure.
Learn how cutting-edge Simoa® technology is uncovering hidden pathways between stress and cognitive decline. [Download Now]
Reference:
- Huang Z, Jordan JD, Zhang Q. Early life adversity as a risk factor for cognitive impairment and Alzheimer’s disease. Transl Neurodegener. 2023;12(1):25. Published 2023 May 12. doi:10.1186/s40035-023-00355-z
- Fleck L, Buss C, Bauer M, et al. Early-Life Adversity Predicts Markers of Aging-Related Neuroinflammation, Neurodegeneration, and Cognitive Impairment in Women. Ann Neurol. 2025;97(4):642-656. doi:10.1002/ana.27161
Frequently Asked Questions About Stress Related Dementia
A: Stress related dementia refers to cognitive decline and neurodegenerative conditions, like Alzheimer’s, that may be triggered or accelerated by chronic stress or early life adversity.
A: Elevated levels of GFAP, NfL, and Tau 181 have been identified as peripheral biomarkers that may signal inflammation and neurodegeneration associated with stress related dementia.
A: Yes. Studies have shown that individuals exposed to high levels of childhood trauma (measured through ACE scores) are at significantly higher risk of developing stress related dementia later in life.